Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting ...
The Standard-Times on MSN1d
How this New Bedford junior became the state's top weight thrower in just over a year
In just over a year, Smith has developed into one of the top throwers in the state and beyond. She is ranked No. 1 in MA and ...
Hims & Hers Health: Meme Potential Could Propel Explosive Growth
Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...
Rolling Out4d
Why healthy weight is more than numbers on a scale
A healthy weight isn’t one-size-fits-all Learn why body composition lifestyle and overall wellness matter more than just a ...
Swastika drawn in Mass. school prompts warning about increase in hate speech
Administrators at Uxbridge High School found a swastika drawn in pencil in the girl’s bathroom Wednesday afternoon.
Antisemitic graffiti found in bathroom at Uxbridge High School
The school administration was notified that a swastika was found on a wall of the girl’s bathroom along with other “vulgar ...
UVA Today6d
UVA Experts Go Beyond BMI To Measure Your Health
As BMI is increasingly recognized as an imperfect way to measure health, UVA researchers share other metrics they rely upon.
Wave Life Sciences USA, Inc.: Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA - a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation) ...